WW International, Inc. (WW)
| Market Cap | 174.04M |
| Revenue (ttm) | 710.64M -9.6% |
| Net Income | 1.06B |
| EPS | 23.82 |
| Shares Out | 10.00M |
| PE Ratio | 0.73 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 234,281 |
| Open | 17.57 |
| Previous Close | 17.96 |
| Day's Range | 17.29 - 18.02 |
| 52-Week Range | 17.21 - 46.95 |
| Beta | 1.06 |
| Analysts | Buy |
| Price Target | 45.17 (+159.45%) |
| Earnings Date | Mar 16, 2026 |
About WW
WW International, Inc. provides weight management products and services in the United States, Germany, Canada, and internationally. It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes, as well as offers guidance and medication access for women reaching perimenopause and menopause. The company also provides Core, a digital subscription product for weight loss and weight management; Core+ tier, a subscription for... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for WW stock is "Buy." The 12-month stock price target is $45.17, which is an increase of 159.45% from the latest price.
News
WW International, Inc. (WGHTQ) Q4 2025 Earnings Call Transcript
WW International, Inc. (WGHTQ) Q4 2025 Earnings Call Transcript
Weight Watchers Announces Fourth Quarter and Full Year 2025 Results
2025 Total Revenue and Adjusted EBITDA 1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% yea...
Weight Watchers Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call
NEW YORK, Feb. 27, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers” or the “Company”) will release its results for the fourth quarter and full year 2025 ended December 3...
Weight Watchers Partners with PVOLVE to Deliver Clinically Validated Strength Workouts to Members in the GLP-1 Era
The new partnership combines Weight Watchers' scientifically-backed medical and behavioral expertise with PVOLVE's clinically-studied method to support members at every age and stage of life The new p...
Weight Watchers Expands Its Integrated GLP-1 Platform with Access to Wegovy® Pill Advancing a New Standard for Long-Term Weight Health
A NovoCare® Recognized Care Provider, Weight Watchers' new Med+ program delivers an integrated GLP-1 care model proven to drive greater weight loss results than medication alone A NovoCare® Recognized...
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era
A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss g...
WW International: First Normal Quarter Shows Signs Of Stability
WW International (WW) delivered a strong Q3, exceeding revenue and EBITDA expectations, driven by its Clinical Business. WW faces ongoing challenges, including declining Behavioral subscribers and cau...
WeightWatchers to sell Novo Nordisk's Wegovy pill after 2026 launch
WeightWatchers' CEO said on Wednesday it plans to sell Novo Nordisk's much-anticipated Wegovy in pill form if it is launched next year in the United States, deepening its tie-up with the Danish obesit...
WW International, Inc. (WW) Q3 2025 Earnings Call Transcript
WW International, Inc. ( WW) Q3 2025 Earnings Call November 6, 2025 8:30 AM EST Company Participants David Helderman - Director of Investor Relations Tara Comonte - President, CEO & Director Felicia ...
WeightWatchers Announces Third Quarter 2025 Results
End of Period Subscribers of 3.0 million, including Clinical Subscribers of 124 thousand Total Revenues of $172 million; Clinical Subscription Revenues of $26 million, up 35% year-over-year Net Loss ...
WeightWatchers International shares climb after partnership with Amazon Pharmacy
Shares of WW International rose nearly 6% in premarket trading on Monday after the company announced a new partnership with Amazon to deliver GLP-1 weight-loss drugs and other prescription medications...
WeightWatchers Collaborates With Amazon Pharmacy to Increase Medication Delivery Speed, Convenience and Savings For Members
NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced a collaborat...
WeightWatchers Launches RxFlexFund™, a New Employer Model for Expanding GLP-1 Coverage
Provides a Differentiated Cost-Sharing Framework for GLP-1 Medications Paired With Clinical Oversight and Proven Behavior Change Support from WeightWatchers Clinic Provides a Differentiated Cost-Shari...
WeightWatchers for Business Annual Report Shows Breakthrough Weight Loss Results and Health Outcomes
Members See 46% Improvement in Work-Related Quality of Life and 53% Improvement in Overall Quality of Life
Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Programme
Groundbreaking Programme Tackles Weight, Symptoms and Stigma, Redefining Menopause Care for Millions Groundbreaking Programme Tackles Weight, Symptoms and Stigma, Redefining Menopause Care for Million...
Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Program
Groundbreaking Program Tackles Weight, Symptoms and Stigma, Redefining Menopause Care for Millions Groundbreaking Program Tackles Weight, Symptoms and Stigma, Redefining Menopause Care for Millions
WeightWatchers Advances International Growth With Strategic Leadership Appointment
Alejandro Bethlen to Lead WeightWatchers' Next Phase of International Growth and Innovation, Building on More Than 50 Years in Global Markets Alejandro Bethlen to Lead WeightWatchers' Next Phase of In...
WW International: Slimmed Down And Poised For Recovery
WW International beat Q2 earnings and revenue estimates post-bankruptcy, but guidance and clinical subscriber attrition drove a surprising sell-off. The investment thesis hinges on insurance partnersh...
WW International, Inc. (WW) Q2 2025 Earnings Call Transcript
WW International, Inc. (NASDAQ:WW) Q2 2025 Earnings Conference Call August 11, 2025 8:30 AM ET Company Participants David Helderman - Director of Investor Relations Felicia DellaFortuna - Chief Finan...
WeightWatchers' stock leaps as weight-loss-drug subscriptions boost revenue
WW International, the company known as WeightWatchers, brought back its full-year outlook when it reported second-quarter results.
WeightWatchers Announces Second Quarter 2025 Results
Successful completion of strategic reorganization, reducing debt by $1.15 billion. In connection with emergence on 6/24/25, fiscal Q2 consists of a "Predecessor" period from 3/30/25 to 6/24/25, and a ...
WeightWatchers Appoints SoulCycle Co-Founder Julie Rice as Chief Experience Officer to Lead Community and Brand Innovation
NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers” or the “Company”), the global leader in science-backed weight management, today announced that longser...
WeightWatchers Reschedules Second Quarter 2025 Earnings Release and Conference Call to Finalize Fresh Start Accounting Adoption in Connection with Emergence
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) reschedules its earnings release and conference call for the quarterly period...
WeightWatchers Schedules Second Quarter 2025 Earnings Conference Call
NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) will release its results for the second quarter 2025 ended June 30, 2025, bef...
WeightWatchers to exit process to cut $1.15 billion debt next week
WW International , formerly known as WeightWatchers, is on track to exit its financial reorganization to cut $1.15 billion in debt next week as part of its bankruptcy process, the weight management fi...